NOVEN ANNOUNCES DISMISSAL OF SECURITIES LITIGATION |
BackMiami, FL, March
17, 2005 -- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) announced today
that the United States District Court for the Southern District of
Florida has issued an order dismissing without prejudice a lawsuit
filed against Noven and certain individual defendants styled In re
Noven Pharmaceuticals, Inc. Securities Litigation.
The notice of voluntary dismissal (attached to the order of dismissal)
indicates that the lead plaintiffs and their counsel, after investigation
into the allegations made in their complaint, concluded that the complaint
should be voluntarily dismissed. Noven agreed to the dismissal, with
each party bearing its own costs.
Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a
leading developer of advanced transdermal drug delivery technologies
and prescription transdermal products. For additional information on
Noven, visit http://www.noven.com.
| Contact: Joseph C. Jones Vice President – Corporate Affairs Noven Pharmaceuticals, Inc. (305) 253-1916 |
Copyright © 2005 Noven Pharmaceuticals, Inc. All rights reserved.